WHO ICTRP trial
The clinical validation of a dried blood spot method for immunosuppressive drugs…
NL-OMON23332 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON23332 |
|---|---|
| Public title | The clinical validation of a dried blood spot method for immunosuppressive drugs and creatinine |
| Scientific title | The clinical validation of a dried blood spot method for immunosuppressive drugs and creatinine |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Conditions | Transplant recipients |
| Interventions | Patients are treated with tacrolimus, everolimus, sirolimus or ciclosporin, in the dose prescribed by their treating physician. In addition to the standard venous samples, DBS samples will be collected from patients visiting the hospital… |
| Registration date | Apr 2, 2020 |
| Target size | 160 |
| Secondary IDs | NL8502;METC Erasmus MC : MEC-2019-0783 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: